Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based Design.
Brouwer, J.M., Lan, P., Cowan, A.D., Bernardini, J.P., Birkinshaw, R.W., van Delft, M.F., Sleebs, B.E., Robin, A.Y., Wardak, A., Tan, I.K., Reljic, B., Lee, E.F., Fairlie, W.D., Call, M.J., Smith, B.J., Dewson, G., Lessene, G., Colman, P.M., Czabotar, P.E.(2017) Mol Cell 68: 659-672.e9
- PubMed: 29149594 
- DOI: https://doi.org/10.1016/j.molcel.2017.11.001
- Primary Citation of Related Structures:  
5VWV, 5VWW, 5VWX, 5VWY, 5VWZ, 5VX0, 5VX1, 5VX2, 5VX3 - PubMed Abstract: 
Certain BH3-only proteins transiently bind and activate Bak and Bax, initiating their oligomerization and the permeabilization of the mitochondrial outer membrane, a pivotal step in the mitochondrial pathway to apoptosis. Here we describe the first crystal structures of an activator BH3 peptide bound to Bak and illustrate their use in the design of BH3 derivatives capable of inhibiting human Bak on mitochondria ...